Diindolylmethane

evidence score
supplement
Evidence Level B
DIM3,3'-diindolylmethaneBioResponse DIM

DIM (3,3'-diindolylmethane) is the primary bioactive metabolite of indole-3-carbinol (I3C), found in cruciferous vegetables (broccoli, cauliflower, cabbage). DIM shifts estrogen metabolism toward the 2-hydroxylation pathway (producing 2-OHE1, a weaker, potentially protective estrogen metabolite) and away from the 16α-hydroxylation pathway (producing 16α-OHE1, a more proliferative metabolite). This 2:16 ratio shift is the primary mechanism of interest for both cancer chemoprevention and TRT estrogen management. In men on TRT, DIM is used as a "natural" estrogen modulator — not an aromatase inhibitor (it doesn't block estrogen production) but a metabolism shifter that redirects estrogen toward less potent metabolites. Clinical trials confirm DIM shifts urinary 2:16-OHE1 ratios in both men and women. It also has anti-androgenic effects at very high doses, so dosing precision matters in TRT contexts. The bioavailability of crystalline DIM is poor; microencapsulated or absorption-enhanced formulations (BioResponse DIM) are standard.

Evidence

No score yet

Safety

Unknown safety profile

Clinical Status

Phase II (cancer prevention); OTC as supplement

Last Sync

Not synced yet

Last Reviewed

Not reviewed yet

Dosing

Typical
200 mg
100 mgRange400 mg
Frequencydaily (with food)

Set height & weight in Settings to see your dose.

Pharmacology

Half-life~2-6 hours
Onset2:16 ratio shift measurable within 2-4 weeks
DurationOngoing with daily dosing; reverses within 1-2 weeks of cessation
Routes
oral

Evidence Score

0 studies indexed
Scoring Factors
Volume(24%)
Quality(24%)
Sample Size(12%)
Consistency(14%)
Replication(8%)
Recency(18%)
Evidence Levels
AScore ≥75 with at least 1 meta-analysis and 3+ RCTs
BScore ≥50 with at least 1 RCT or meta-analysis
CScore ≥25 — observational or animal evidence only
DScore <25 — very limited or preclinical data

Plain-English Snapshot

Diindolylmethane is currently categorized as a supplement compound.

Evidence scoring has not been fully computed yet, so interpret this profile as preliminary.

Safety scoring is incomplete. Start conservatively and monitor carefully.

Core mechanism

Shifts estrogen metabolism toward 2-hydroxylation (2-OHE1) and away from 16α-hydroxylation (16α-OHE1); modulates estrogen receptor signaling without blocking aromatase

Practical Context

Strongest current signals

No indexed study summaries yet.

Compound Profile